210 related articles for article (PubMed ID: 37669127)
1. Unveiling the Ghrelin and Obestatin Roles in Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis Assessing Their Pathogenic Implications and Biomarker Utility.
Khalaji A; Babajani N; Amirsardari Z; Saeedian B; Peiman S; Berger NA; Behnoush AH
Inflamm Bowel Dis; 2024 Apr; 30(4):629-640. PubMed ID: 37669127
[TBL] [Abstract][Full Text] [Related]
2. Circulatory resistin levels in inflammatory bowel disease: a systematic review and meta-analysis.
Behnoush AH; Maroufi SP; Reshadmanesh T; Mohtasham Kia Y; Norouzi M; Mohammadi SM; Klisic A; Khalaji A
BMC Gastroenterol; 2024 Mar; 24(1):107. PubMed ID: 38486190
[TBL] [Abstract][Full Text] [Related]
3. Obestatin/ghrelin ratio: a new activity index in inflammatory bowel diseases.
Alexandridis E; Zisimopoulos A; Liratzopoulos N; Katsos I; Manolas K; Kouklakis G
Inflamm Bowel Dis; 2009 Oct; 15(10):1557-61. PubMed ID: 19408254
[TBL] [Abstract][Full Text] [Related]
4. Blood regulatory T cells in inflammatory bowel disease, a systematic review, and meta-analysis.
Jalalvand M; Enayati S; Akhtari M; Madreseh E; Jamshidi A; Farhadi E; Mahmoudi M; Amirzargar A
Int Immunopharmacol; 2023 Apr; 117():109824. PubMed ID: 36827916
[TBL] [Abstract][Full Text] [Related]
5. Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.
Sinopoulou V; Gordon M; Akobeng AK; Gasparetto M; Sammaan M; Vasiliou J; Dovey TM
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD013531. PubMed ID: 34844288
[TBL] [Abstract][Full Text] [Related]
6. Systematic review and meta-analysis of the role of Faecalibacterium prausnitzii alteration in inflammatory bowel disease.
Zhao H; Xu H; Chen S; He J; Zhou Y; Nie Y
J Gastroenterol Hepatol; 2021 Feb; 36(2):320-328. PubMed ID: 32815163
[TBL] [Abstract][Full Text] [Related]
7. Peripheral blood neutrophil-to-lymphocyte ratio in inflammatory bowel disease and disease activity: A meta-analysis.
Fu W; Fu H; Ye W; Han Y; Liu X; Zhu S; Li H; Tang R; Wang Q
Int Immunopharmacol; 2021 Dec; 101(Pt B):108235. PubMed ID: 34678692
[TBL] [Abstract][Full Text] [Related]
8. Fecal transplantation for treatment of inflammatory bowel disease.
Imdad A; Nicholson MR; Tanner-Smith EE; Zackular JP; Gomez-Duarte OG; Beaulieu DB; Acra S
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012774. PubMed ID: 30480772
[TBL] [Abstract][Full Text] [Related]
9. Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease.
Karmiris K; Koutroubakis IE; Xidakis C; Polychronaki M; Voudouri T; Kouroumalis EA
Inflamm Bowel Dis; 2006 Feb; 12(2):100-5. PubMed ID: 16432373
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of probiotics in the induction and maintenance of inflammatory bowel disease remission: a systematic review and meta-analysis.
Chen M; Feng Y; Liu W
Ann Palliat Med; 2021 Nov; 10(11):11821-11829. PubMed ID: 34872306
[TBL] [Abstract][Full Text] [Related]
11. Helminth therapy (worms) for induction of remission in inflammatory bowel disease.
Garg SK; Croft AM; Bager P
Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD009400. PubMed ID: 24442917
[TBL] [Abstract][Full Text] [Related]
12. Adiponectin Levels in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
Surdea-Blaga T; Ismaiel A; Jaaouani A; Leucuta DC; Elsayed A; Ismaiel M; Ben Ameur I; Al Srouji N; Popa SL; Grad S; Ensar D; Dumitrascu DL
Dig Dis; 2023; 41(6):860-871. PubMed ID: 37385235
[TBL] [Abstract][Full Text] [Related]
13. Dietary interventions for induction and maintenance of remission in inflammatory bowel disease.
Limketkai BN; Iheozor-Ejiofor Z; Gjuladin-Hellon T; Parian A; Matarese LE; Bracewell K; MacDonald JK; Gordon M; Mullin GE
Cochrane Database Syst Rev; 2019 Feb; 2(2):CD012839. PubMed ID: 30736095
[TBL] [Abstract][Full Text] [Related]
14. Faecal Microbiota Transplantation for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
Paramsothy S; Paramsothy R; Rubin DT; Kamm MA; Kaakoush NO; Mitchell HM; Castaño-Rodríguez N
J Crohns Colitis; 2017 Oct; 11(10):1180-1199. PubMed ID: 28486648
[TBL] [Abstract][Full Text] [Related]
15. Visceral adiposity and inflammatory bowel disease.
Rowan CR; McManus J; Boland K; O'Toole A
Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
[TBL] [Abstract][Full Text] [Related]
16. Circulating ghrelin levels and obestatin/ghrelin ratio as a marker of activity in ulcerative colitis.
Jung JY; Jeong JB; Kim JW; Kim SH; Koh SJ; Kim BG; Lee KL
Intest Res; 2015 Jan; 13(1):68-73. PubMed ID: 25691845
[TBL] [Abstract][Full Text] [Related]
17. Systematic Review and Meta-analysis: Short-Chain Fatty Acid Characterization in Patients With Inflammatory Bowel Disease.
Zhuang X; Li T; Li M; Huang S; Qiu Y; Feng R; Zhang S; Chen M; Xiong L; Zeng Z
Inflamm Bowel Dis; 2019 Oct; 25(11):1751-1763. PubMed ID: 31498864
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory bowel disease and the risk of intracerebral hemorrhage: A Mendelian randomization study and meta-analysis.
Song Y; Zou X; Zeng Y; Zhang L; Mao X
Immun Inflamm Dis; 2023 Oct; 11(10):e1048. PubMed ID: 37904677
[TBL] [Abstract][Full Text] [Related]
19. Fecal Lactoferrin for Assessment of Inflammatory Bowel Disease Activity: A Systematic Review and Meta-Analysis.
Dai C; Jiang M; Sun MJ; Cao Q
J Clin Gastroenterol; 2020 Jul; 54(6):545-553. PubMed ID: 30994521
[TBL] [Abstract][Full Text] [Related]
20. Patient education interventions for the management of inflammatory bowel disease.
Gordon M; Sinopoulou V; Ibrahim U; Abdulshafea M; Bracewell K; Akobeng AK
Cochrane Database Syst Rev; 2023 May; 5(5):CD013854. PubMed ID: 37172140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
